Retained Earnings (Accumulated Deficit) of Pharma-Bio Serv, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Pharma-Bio Serv, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Pharma-Bio Serv, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Oct 2025 was $10,533,589, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,533,589 -$1,820,381 -15% 31 Oct 2025 10-K 29 Jan 2026 2025 FY
Q2 2025 $10,533,691 -$1,804,168 -15% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $10,737,941 -$1,909,112 -15% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $10,642,588 -$2,218,282 -17% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $12,353,970 -$2,499,856 -17% 31 Oct 2024 10-K 29 Jan 2026 2025 FY
Q2 2024 $12,337,859 -$2,563,115 -17% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $12,647,053 -$1,727,679 -12% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $12,860,870 -$2,833,032 -18% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $14,853,826 -$413,644 -2.7% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $14,900,974 -$193,117 -1.3% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $14,374,732 -$431,325 -2.9% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $15,693,902 -$596,332 -3.7% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $15,267,470 -$2,439,914 -14% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $15,094,091 -$7,485,954 -33% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $14,806,057 -$5,498,870 -27% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $16,290,234 -$3,774,422 -19% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $17,707,384 -$3,816,606 -18% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $22,580,045 +$1,200,402 +5.6% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $20,304,927 -$382,602 -1.8% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $20,064,656 +$64,688 +0.32% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $21,523,990 +$2,050,921 +11% 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $21,379,643 +$658,874 +3.2% 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $20,687,529 +$397,918 +2% 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $19,999,968 +$417,837 +2.1% 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $19,473,069 +$361,958 +1.9% 31 Oct 2019 10-K 01 Feb 2021 2020 FY
Q2 2019 $20,720,769 +$3,222,367 +18% 31 Jul 2019 10-Q 16 Sep 2019 2019 Q3
Q1 2019 $20,289,611 +$3,521,840 +21% 30 Apr 2019 10-Q 14 Jun 2019 2019 Q2
Q4 2018 $19,582,131 +$2,686,012 +16% 31 Jan 2019 10-Q 18 Mar 2019 2019 Q1
Q3 2018 $19,111,111 -$449,020 -2.3% 31 Oct 2018 10-K 29 Jan 2020 2019 FY
Q2 2018 $17,498,402 -$2,608,758 -13% 31 Jul 2018 10-Q 14 Sep 2018 2018 Q3
Q1 2018 $16,767,771 -$3,502,371 -17% 30 Apr 2018 10-Q 14 Jun 2018 2018 Q2
Q4 2017 $16,896,119 -$3,696,786 -18% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q1
Q3 2017 $19,560,131 -$1,414,919 -6.7% 31 Oct 2017 10-K 29 Jan 2019 2018 FY
Q2 2017 $20,107,160 -$1,381,206 -6.4% 31 Jul 2017 10-Q 14 Sep 2017 2017 Q3
Q1 2017 $20,270,142 -$1,348,697 -6.2% 30 Apr 2017 10-Q 14 Jun 2017 2017 Q2
Q4 2016 $20,592,905 -$988,732 -4.6% 31 Jan 2017 10-Q 17 Mar 2017 2017 Q1
Q3 2016 $20,975,050 -$256,579 -1.2% 31 Oct 2016 10-K 29 Jan 2018 2017 FY
Q2 2016 $21,488,366 +$780,189 +3.8% 31 Jul 2016 10-Q 14 Sep 2016 2016 Q3
Q1 2016 $21,618,839 +$1,364,635 +6.7% 30 Apr 2016 10-Q 14 Jun 2016 2016 Q2
Q4 2015 $21,581,637 +$1,686,440 +8.5% 31 Jan 2016 10-Q 16 Mar 2016 2016 Q1
Q3 2015 $21,231,629 +$1,624,812 +8.3% 31 Oct 2015 10-K 31 Jan 2017 2016 FY
Q2 2015 $20,708,177 +$1,928,237 +10% 31 Jul 2015 10-Q 14 Sep 2015 2015 Q3
Q1 2015 $20,254,204 +$2,071,324 +11% 30 Apr 2015 10-Q 15 Jun 2015 2015 Q2
Q4 2014 $19,895,197 +$2,040,091 +11% 31 Jan 2015 10-Q 17 Mar 2015 2015 Q1
Q3 2014 $19,606,817 +$2,413,614 +14% 31 Oct 2014 10-K 29 Jan 2016 2015 FY
Q2 2014 $18,779,940 +$2,806,186 +18% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 $18,182,880 +$3,455,641 +23% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 $17,855,106 +$4,515,147 +34% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $17,193,203 +$4,906,489 +40% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 $15,973,754 +$4,763,604 +42% 31 Jul 2013 10-Q 16 Sep 2013 2013 Q3
Q1 2013 $14,727,239 +$4,792,988 +48% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q2
Q4 2012 $13,339,959 +$4,593,717 +53% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q1
Q3 2012 $12,286,714 +$4,687,006 +62% 31 Oct 2012 10-K 29 Jan 2014 2013 FY
Q2 2012 $11,210,150 +$4,434,869 +65% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 $9,934,251 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 $8,746,242 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 $7,599,708 +$3,158,980 +71% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 $6,775,281 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 $4,440,728 31 Oct 2010 10-K/A 31 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.